Check out our Review article about adoptive regulatory T cell therapy: frontiersin.org/articles/10.33…

check out our TReAT project website: treat-project.com

Delighted to share our study on limiting translocations in multiplex-edited CAR-T cells created by non-viral #CRISPR gene editing was published #OpenAccess Genome Biology. 🥳🥳🥳genomebiology.biomedcentral.com/articles/10.11… (1/4)

Our Phd student Niklas Wiese at #CIMT2023 with the technical account manager from #ScaleReady discussing about the future of T-Cell cultivation for future #Immunotherapies

We are happy to be part of this broad scientific community! Charité - Universitätsmedizin Berlin @BIHregeneration Charité BIH Innovation

It was a pleasure to participate at #LNDW23 @BIHregeneration and dive into the world of #antiviral #TCell #Immunology

Check out this thread on our latest story describing a novel in process purification of allogeneic TCR-edited CAR T cells using an NK cell line, spearheaded by the one and only Jonas Kath 🥳 Blood Advances

Wrapping up on the last day of #ICLE23 with friends and colleagues. It was a blast!! @LabMsh Dimitrios L. Wagner Sarah Schulenberg Viktor Glaser

BREAKING NEWS The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

Ending the year with a great TReAT meeting with many of our collaboration partners. Discussing achieved goals and next steps for 2024 🥳 Thank you all for your great efforts! @LabMsh Oliver Klein Leila Amini

Our phd student Claudia won the 3rd poster price at the BSRT Symposium @BIHregeneration 🥳🥳🥳

It was a pleasure to attend #FOCIS2024 in San Francisco and present our recent findings on virus-specific tacrolimus-resistant T-cells. We were excited to share our work and connect with researchers from around the world!